CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
REVENUES:
Net product sales	$ 27,515,786	$ 24,327,355
License and royalty revenue	4,906	0
R&D, milestone and grant revenue	2,028,917	1,283,240
TOTAL REVENUES	29,549,609	25,610,595
Cost of product sales	17,249,450	14,820,604
GROSS MARGIN	12,300,159	10,789,991
OPERATING EXPENSES:
Research and development expenses	5,834,249	4,486,302
Selling, general and administrative expenses	5,461,083	4,851,587
TOTAL OPERATING EXPENSES	11,295,332	9,337,889
INCOME FROM OPERATIONS	1,004,827	1,452,102
OTHER INCOME (EXPENSES):
Interest income	5,778	7,911
Gain (Loss) on Sale of fixed assets	7,500	0
Interest expense	(335)	(9,495)
TOTAL OTHER INCOME (EXPENSES)	12,943	(1,584)
INCOME BEFORE INCOME TAXES	1,017,770	1,450,518
Income tax provision (benefit)	486,952	509,237
NET INCOME	$ 530,818	$ 941,281
Basic earnings per share (in dollars per share)	$ 0.06	$ 0.12
Diluted earnings (loss) per share (in dollars per share)	$ 0.06	$ 0.11
Weighted average number of shares outstanding, basic (in shares)	8,994,080	7,986,030
Weighted average number of shares outstanding, diluted (in shares)	9,519,968	8,614,944